Vigabatrin Patent Expiration

Vigabatrin was first introduced by Lundbeck Pharmaceuticals Llc in its drug Sabril on Aug 21, 2009. Another drug containing Vigabatrin is Vigafyde. 22 different companies have introduced drugs containing Vigabatrin.


Vigabatrin Patents

Given below is the list of patents protecting Vigabatrin, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Vigafyde US12290499 Vigabatrin liquid pharmaceutical composition Oct 17, 2042 Pyros Pharms
Vigafyde US12016857 Stable liquid vigabatrin pharmaceutical composition for oral dosage Aug 16, 2039 Pyros Pharms



Vigabatrin's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Vigabatrin Generic API Manufacturers

Several generic applications have been filed for Vigabatrin. The first generic version for Vigabatrin was by Ph Health Ltd and was approved on Apr 27, 2017. And the latest generic version is by Upsher Smith Laboratories Llc and was approved on Jun 29, 2023.

Given below is the list of companies who have filed for Vigabatrin generic, along with the locations of their manufacturing plants worldwide.